ADJUVANT DRUG THERAPY
Clinical trials for ADJUVANT DRUG THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT DRUG THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT DRUG THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could tailoring tamoxifen doses keep more breast cancer patients on treatment?
Disease control Not yet recruitingThis phase 3 trial tests whether giving breast cancer patients a personalized dose of tamoxifen (based on how their body processes the drug) helps them stay on treatment longer and have better outcomes. Currently, 30-50% of patients stop taking tamoxifen early due to side effects…
Matched conditions: ADJUVANT DRUG THERAPY
Phase: PHASE3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New study aims to protect older breast cancer patients from hidden drug risks
Knowledge-focused Not yet recruitingThis study follows 200 breast cancer patients aged 70 and older who are starting a combination of CDK4/6 inhibitors and hormone therapy after surgery. Researchers want to see if simple geriatric screening tests can predict who will have side effects or a drop in quality of life. …
Matched conditions: ADJUVANT DRUG THERAPY
Sponsor: Region Jönköping County • Aim: Knowledge-focused
Last updated May 25, 2026 06:49 UTC